Skip to content
Discover J&J
Medicines & therapies
Medical devices & technology
Discover J&J
Medicines & therapies
Medical devices & technology
Center for
U.S. Healthcare
Policy Research
Research
areas
Research areas
Value
Access
Innovation
All content
Transparency Report
& Issue Briefs
Perspectives
& insights
About us
Menu
Center for
U.S. Healthcare
Policy Research
Research
areas
Research areas
Value
Access
Innovation
All content
Transparency Report
& Issue Briefs
Perspectives
& insights
About us
Show Search
Search Query
Clear
Submit Search
Dictate search request
Listening...
Search Results
No Results
See all results
Sorry, I don't understand. Please try again
Home
/
Content library
Content library
Explore all content
Search Query
Submit Search
Clear
Dictate search request
Sorry, I don't understand. Please try again
Date
All (19)
2025 (11)
2024 (4)
2023 (2)
Category
All (65)
Perspectives & insights (26)
Research (19)
Transparency Report & Issue Briefs (21)
Tag
All (19)
340B (2)
Access (11)
Innovation & R&D (4)
Insurance Design Reform & PBMs (1)
Prescription Drug Affordability Boards (PDABs) and Upper Payment Limits (UPLs) (1)
Value (3)
Value Assessment (1)
There are 19 results that match your search.
Filters
1
Date
All (19)
2025 (11)
2024 (4)
2023 (2)
Category
1
All (65)
Perspectives & insights (26)
Research (19)
Transparency Report & Issue Briefs (21)
Tag
All (19)
340B (2)
Access (11)
Innovation & R&D (4)
Insurance Design Reform & PBMs (1)
Prescription Drug Affordability Boards (PDABs) and Upper Payment Limits (UPLs) (1)
Value (3)
Value Assessment (1)
Newest
Newest
Oldest
Relevance
Access
January 27, 2026
Do expedited FDA approvals translate to faster insurance coverage?
Read more
Access
January 12, 2026
How does non-medical switching affect patient outcomes?
A systematic review highlights its negative consequences
Read more
Access
December 23, 2025
Are employer-sponsored health plans meeting the needs of patients with chronic disease?
Read more
Access
December 23, 2025
How do patients with chronic illness experience health insurance, and what do they believe needs to change?
Read more
Access
December 23, 2025
Non-medical switching among AFib patients: Disruptions in treatment
Read more
Value
November 25, 2025
Tailoring generalized cost-effectiveness analysis (GCEA) to the U.S. setting: The importance of using the right prices
Read more
Value
Understanding state Medicaid spending on prescription drugs
This analysis demonstrates that state Medicaid programs are estimated to be spending near or below the national average on prescription drugs.
Read more
Access
Influence of Prescription Drug Affordability Boards and Upper Payment Limits on state drug pricing
Read more
Value
November 3, 2025
Are state prescription drug affordability boards (PDABs) and upper payment limits (UPLs) achieving their intended goals?
Read more
Value
October 27, 2025
Are cost-effectiveness analysis thresholds fit for purpose for U.S. decision-making?
Read more
Load more
